EMA Reviewing Two MAb Combinations For COVID-19
Products Being Assessed Under Special Procedure For EU Member States
The European Medicines Agency's special review process that was used to help EU member states issue emergency use approvals for dexamethasone in COVID-19 patients is now being applied to two antibody combinations from Regeneron/Roche and Lilly.
